An official website of the United States government
Suprachoroidal Administration in Subjects With Metastases to the Choroid
Trial Status: active
The primary objective is to assess the safety and tolerability of bel-sar treatment in
subjects with metastases to the choroid from any primary carcinoma.
Inclusion Criteria
Have a clinical diagnosis of Metastases to the Choroid, from a histopathologically or cytologically confirmed tumor.
Have at least one Metastases to the Choroid in the study eye
Exclusion Criteria
Active ocular infection or disease.
Must not have evidence of a primary tumor or metastatic lesion in the brain requiring treatment with radiation therapy per the primary treating oncologist's assessment.
Must not be planning or expecting to switch/add systemic antineoplastic therapies during treatment
Additional locations may be listed on ClinicalTrials.gov for NCT06643884.
Locations matching your search criteria
United States
Florida
Miami
University of Miami Miller School of Medicine-Sylvester Cancer Center
Status: Active
Name Not Available
Michigan
Ann Arbor
University of Michigan Comprehensive Cancer Center
Status: Active
Name Not Available
Washington
Seattle
Fred Hutch/University of Washington/Seattle Children's Cancer Consortium
Status: Active
Name Not Available
This is an open-label, dose escalation trial designed to assess safety and tolerability
of 4 dose strengths and 1-2 cycles of bel-sar treatment in subjects with metastases to
